VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,134,661 | -14.6% | 301,580 | 0.0% | 0.27% | +2.3% |
| Q2 2023 | $4,840,359 | +106.8% | 301,580 | 0.0% | 0.26% | +100.0% |
| Q1 2023 | $2,340,261 | -59.9% | 301,580 | 0.0% | 0.13% | -61.7% |
| Q4 2022 | $5,835,573 | -9.2% | 301,580 | 0.0% | 0.34% | +3.4% |
| Q3 2022 | $6,427,000 | +56.6% | 301,580 | 0.0% | 0.33% | +47.1% |
| Q2 2022 | $4,105,000 | -42.1% | 301,580 | 0.0% | 0.22% | -3.0% |
| Q1 2022 | $7,084,000 | -62.9% | 301,580 | -57.7% | 0.23% | -50.0% |
| Q4 2021 | $19,069,000 | +16.3% | 713,658 | -24.5% | 0.46% | +18.3% |
| Q3 2021 | $16,392,000 | +30.8% | 944,791 | 0.0% | 0.39% | +52.5% |
| Q2 2021 | $12,528,000 | – | 944,791 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,372,428 | $26,170,041 | 3.38% |
| COMMODORE CAPITAL LP | 2,824,029 | $21,914,465 | 3.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,002,257 | $7,747,447 | 2.16% |
| Sofinnova Investments, Inc. | 3,467,156 | $26,905,131 | 1.72% |
| Altium Capital Management LP | 286,000 | $2,219,360 | 1.23% |
| Eversept Partners, LP | 1,788,529 | $13,878,985 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 600,300 | $4,658,328 | 0.90% |
| Octagon Capital Advisors LP | 795,000 | $6,169,200 | 0.89% |
| Carlyle Group Inc. | 2,960,231 | $22,882,586 | 0.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,300,000 | $10,088,000 | 0.22% |